PODCAST · education
RadOnc Smart Review
by Abass Conteh
AI Generated Podcast reviewing various topics in Radiation Oncology for Residents on the go.
Episodes
-
G.I. E30: Anal Response, Surveillance, Toxicity, Salvage, and Future Directions.
Episode 30: Anal Response, Surveillance, Toxicity, Salvage, and Future Directions.After anal chemoradiation, a resolving lesion and progressive disease call for different decisions. In this episode, we distinguish response-assessment timelines, surveillance, biopsy and salvage, while addressing...
-
G.I. E29: Anal IMRT Planning: Simulation, Contouring, Dose Painting, and Special Populations.
Episode 29: Anal IMRT Planning: Simulation, Contouring, Dose Painting, and Special Populations.A correct prescription alone does not guarantee a sound anal IMRT plan. In this episode, we work through reproducible simulation, gross and elective target delineation, nodal compartments, dose…
more -
G.I. E28: Anal Chemoradiation: Chemotherapy, Dose, Timing, and Evidence.
Episode 28: Anal Chemoradiation: Chemotherapy, Dose, Timing, and Evidence.A complete anal chemoradiation plan brings together concurrent chemotherapy, target-specific dose, and treatment timing. In this episode, we examine the evidence behind regimen choices, interpret RTOG 98-11 and ACT II in...
-
G.I. E27: Anal Cancer Foundations: Anatomy, Staging, Workup, and the Nigro Paradigm.
Episode 27: Anal Cancer Foundations: Anatomy, Staging, Workup, and the Nigro Paradigm.Anal cancer management begins by locating the primary and distinguishing anal canal from anal margin disease. In this episode, we review examination, imaging, lymphatic drainage, staging, and patient context…
more -
G.I. E26: Rectal Planning, Pelvic Recurrence, Reirradiation, Toxicity, and Survivorship.
Episode 26: Rectal Planning, Pelvic Recurrence, Reirradiation, Toxicity, and Survivorship.Initial rectal treatment and pelvic recurrence both require a careful reconstruction of anatomy and treatment intent. In this episode, we work through simulation, targets, dose, salvage assessment, and...
-
G.I. E25: Rectal Organ Preservation: Watch-and-Wait and dMMR Immunotherapy.
Episode 25: Rectal Organ Preservation: Watch-and-Wait and dMMR Immunotherapy.Rectal organ preservation depends on more than a reassuring scan. In this episode, we examine clinical response assessment, watch-and-wait surveillance, regrowth and salvage, and the OPRA sequence, then consider the...
-
G.I. E24: Selective Radiation Omission: PROSPECT, Upfront Surgery, and Local Excision.
Episode 24: Selective Radiation Omission: PROSPECT, Upfront Surgery, and Local Excision.Selective radiation omission in rectal cancer requires a defined treatment algorithm and careful eligibility assessment. In this episode, we reconstruct PROSPECT selection, chemotherapy, response assessment…
more -
G.I. E23: Total Neoadjuvant Therapy: RAPIDO, PRODIGE 23, STELLAR, and OPRA.
Episode 23: Total Neoadjuvant Therapy: RAPIDO, PRODIGE 23, STELLAR, and OPRA.Total neoadjuvant therapy is a set of treatment strategies, not a single regimen. In this episode, we compare RAPIDO, PRODIGE 23, STELLAR, and OPRA in their own populations and sequences, examining distant control, local...
-
G.I. E22: Rectal Neoadjuvant Radiation: Long Course, Short Course, and Surgical Timing.
Episode 22: Rectal Neoadjuvant Radiation: Long Course, Short Course, and Surgical Timing.Long-course chemoradiation and short-course radiation are treatment platforms whose timing and purpose matter. In this episode, we compare their evidence, patient selection, concurrent chemotherapy, and...
-
G.I. E21: Rectal Cancer Foundations: MRI Staging, Anatomy, TME, and Risk Stratification.
Episode 21: Rectal Cancer Foundations: MRI Staging, Anatomy, TME, and Risk Stratification.Rectal cancer treatment begins with a precise anatomic and MRI-based assessment. In this episode, we review tumor height, pelvic anatomy, mesorectal fascia, vascular invasion, nodal compartments, and total...
-
G.I. E20: Rare GI Malignancies: Small Bowel, Duodenum, Appendix, GIST, and Neuroendocrine Tumors.
Episode 20: Rare GI Malignancies: Small Bowel, Duodenum, Appendix, GIST, and Neuroendocrine Tumors.Rare gastrointestinal malignancies do not share a single treatment pathway. In this episode, we distinguish small bowel and duodenal cancers, appendiceal tumors, GIST, and neuroendocrine neoplasms,...
-
G.I. E19: Colorectal Oligometastases: Liver and Lung Surgery, Ablation, SBRT, and COLLISION.
Episode 19: Colorectal Oligometastases: Liver and Lung Surgery, Ablation, SBRT, and COLLISION.Choosing a local treatment for colorectal liver or lung metastases starts with whether complete clearance is feasible. In this episode, we compare the roles of surgery, ablation, and SBRT within...
-
G.I. E18: Metastatic Colorectal Cancer: Molecular Selection and Systemic Therapy.
Episode 18: Metastatic Colorectal Cancer: Molecular Selection and Systemic Therapy.A first-line metastatic colorectal cancer plan needs a complete molecular and clinical picture. In this episode, we examine mismatch repair, RAS, BRAF, HER2, other actionable alterations, and primary sidedness…
more -
G.I. E17: Localized Colon Cancer: Staging, Surgery, Adjuvant Therapy, and the Limited Role of Radiation.
Episode 17: Localized Colon Cancer: Staging, Surgery, Adjuvant Therapy, and the Limited Role of Radiation.After colon cancer surgery, the next step depends on stage, pathologic risk, mismatch-repair status, and the precise site of the primary. In this episode, we review staging, surgery, and...
-
G.I. E16: Advanced Biliary Tract Cancer: Systemic Therapy, Biomarkers, and Local Therapy.
Episode 16: Advanced Biliary Tract Cancer: Systemic Therapy, Biomarkers, and Local Therapy.Advanced biliary tract cancer care must bring urgent biliary problems, systemic treatment, and molecular profiling into the same plan. In this episode, we examine anatomic subtype, obstruction and…
more -
G.I. E15: Resectable Biliary Tract Cancer: Surgery, Adjuvant Therapy, and Radiation.
Episode 15: Resectable Biliary Tract Cancer: Surgery, Adjuvant Therapy, and Radiation.A postoperative biliary cancer referral needs more detail than a diagnosis and a positive-margin label. In this episode, we connect anatomic subtype, the operation, pathology, and recurrence risk to adjuvant...
-
G.I. E14: HCC Radiation: EBRT, SBRT, Protons, Planning, and Integration.
Episode 14: HCC Radiation: EBRT, SBRT, Protons, Planning, and Integration.Radiation for HCC requires a clear local-treatment goal and careful protection of the remaining liver. In this episode, we examine EBRT, SBRT, protons, and their integration with other therapies, review comparative evidence...
-
G.I. E13: HCC Foundations: Diagnosis, Liver Function, Staging, and Multidisciplinary Selection.
Episode 13: HCC Foundations: Diagnosis, Liver Function, Staging, and Multidisciplinary Selection.An HCC treatment decision depends on both the cancer and the liver that must tolerate treatment. In this episode, we work through diagnosis, liver reserve, portal hypertension, staging, and...
-
G.I. E12: Pancreas Planning Workshop: Simulation, Targets, Motion, and Constraints.
Episode 12: Pancreas Planning Workshop: Simulation, Targets, Motion, and Constraints.A pancreatic radiation prescription must fit the patient's anatomy and the motion seen at simulation. In this planning workshop, we work through simulation, image registration, target definition, respiratory...
-
G.I. E11: Locally Advanced Pancreas: Chemotherapy, Chemoradiation, SBRT, and Adaptation.
Episode 11: Locally Advanced Pancreas: Chemotherapy, Chemoradiation, SBRT, and Adaptation.For a patient with locally advanced pancreatic cancer, treatment goals and the limits of each modality need to be clear from the start. In this episode, we examine systemic therapy, chemoradiation, SBRT, and...
-
G.I. E10: Resectable and Borderline-Resectable Pancreas: Perioperative Strategy.
Episode 10: Resectable and Borderline-Resectable Pancreas: Perioperative Strategy.Choosing surgery first or preoperative therapy in pancreatic cancer requires more than a resectability label. In this episode, we compare clearly resectable and borderline-resectable pathways, review adjuvant…
more -
G.I. E09: Pancreatic Cancer: Workup, Anatomy, Staging, and Resectability.
Episode 9: Pancreatic Cancer: Workup, Anatomy, Staging, and Resectability.Pancreatic cancer needs both an anatomic stage and a clear description of resectability. In this episode, we follow a pancreatic-head presentation through diagnosis, imaging, obstruction management, surgical anatomy, and…
more -
G.I. E08: Metastatic Gastric and GEJ Cancer: Biomarkers, Systemic Therapy, and Palliation.
Episode 8: Metastatic Gastric and GEJ Cancer: Biomarkers, Systemic Therapy, and Palliation.Metastatic gastric and GEJ cancer requires a treatment plan built around symptoms, fitness, goals, and biomarkers. In this episode, we review tissue assessment and the HER2, PD-L1, mismatch-repair, and...
-
G.I. E07: Gastric Radiation: Indications, Evidence, and Treatment Planning.
Episode 7: Gastric Radiation: Indications, Evidence, and Treatment Planning.Before planning gastric radiation, the team must define the local problem it is meant to address. In this episode, we examine the indications and trial evidence in the context of surgical quality, margins, and systemic...
-
G.I. E06: Gastric Cancer Foundations: Staging, Surgery, and Perioperative Therapy.
Episode 6: Gastric Cancer Foundations: Staging, Surgery, and Perioperative Therapy.A gastric cancer treatment plan begins with the primary site, complete staging, surgical feasibility, and the patient's ability to complete multimodality care. In this episode, we follow an antral cancer case…
more -
G.I. E05: Adjuvant Therapy, Active Surveillance, and Advanced Esophageal Cancer.
Episode 5: Adjuvant Therapy, Active Surveillance, and Advanced Esophageal Cancer.A good response to treatment can lead to very different next steps in esophageal cancer. In this episode, we distinguish adjuvant therapy after resection, active surveillance after a carefully assessed clinical...
-
G.I. E04: Definitive Esophageal Chemoradiation: Dose, Technique, Response, and Salvage.
Episode 4: Definitive Esophageal Chemoradiation: Dose, Technique, Response, and Salvage.Definitive chemoradiation requires a complete plan for patients with esophageal cancer who are not proceeding to surgery. In this episode, we work through patient selection, concurrent treatment, dose…
more -
G.I. E03:Resectable Esophageal and GEJ Cancer: CROSS, FLOT, and Perioperative Selection.
Episode 3: Resectable Esophageal and GEJ Cancer: CROSS, FLOT, and Perioperative Selection. The modern approach to resectable esophageal cancer has evolved beyond simply asking if a patient needs preoperative treatment; for most locally advanced cancers, the answer is yes. In this episode, we dive...
-
G.I. E02: Esophageal and GEJ Cancer Anatomy, Workup, Staging, and Surgery.
Episode 2: Esophageal and GEJ Cancer Anatomy, Workup, Staging, and Surgery. In this episode, we explore how esophageal cancer punishes imprecise anatomy. We discuss why a difference of just a few centimeters can fundamentally alter the primary site, staging schema, regional nodal map, operative...
-
G.I. E01: Foundations, Workup, Intent, Planning Safety, and Cross Cutting Toxicity
This is Episode one: G I Oncology Foundations, Workup, Intent, Planning Safety, and Cross Cutting Toxicity.The most dangerous G I oncology error is often not choosing the wrong dose. It is answering the dose question before proving the diagnosis, stage, treatment intent, and problem that…
more -
Thoracic E30: Comprehensive Thoracic Mock Oral Review
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 30 is the comprehensive Thoracic mock oral. Three case blocks cover metastatic disease with consolidation versus oligoprogression, superior vena cava syndrome and thymic carcinoma, and a post-treatment pulmonary syndrome...
-
Thoracic E29: Thoracic Oncology Board Synthesis
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 29 is a board-synthesis workshop built around the order of operations that keeps thoracic decisions safe. We move from diagnosis and stage uncertainty to management-changing workup, invasive staging, operability,...
-
Thoracic E28: Thoracic Reirradiation and Cumulative Dose
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 28 approaches thoracic reirradiation as a new treatment decision made in the shadow of a prior course. Before discussing dose, we define intent, alternatives, expected benefit, prior-plan reconstruction, registration...
-
Thoracic E27: Thoracic Toxicity: Prevention, Recognition, and Differential Diagnosis
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 27 tackles thoracic toxicity as a differential-diagnosis problem. Cough, dyspnea, dysphagia, fever, fatigue, chest discomfort, and palpitations may reflect radiation injury, infection, recurrent cancer, airway obstruction,...
-
Thoracic E26: Pleural Mesothelioma
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 26 treats pleural mesothelioma as the surface-spreading disease it is—not as a spherical lung mass. We cover diagnostic adequacy, histology, anatomic extent, operability, and whether meaningful cytoreduction is achievable...
-
Thoracic E25: Thymic Malignancies and Selected Rare Thoracic Tumors
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 25 uses thymic malignancies to build a disciplined approach to rare thoracic tumors. We address diagnostic pathways, myasthenic symptoms, biopsy-route hazards, the difference between operability and an R0 resection, true...
-
Thoracic E24: Thoracic Palliation and Oncologic Emergencies
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 24 brings structure to thoracic palliation and oncologic emergencies. We balance the danger of moving too slowly during airway, vascular, spinal-cord, pericardial, or respiratory compromise against the harm of giving empiric...
-
Thoracic E23: Oligometastatic and Oligoprogressive Non-Small-Cell Lung Cancer
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 23 separates two often-confused strategies in limited metastatic non-small cell lung cancer: comprehensive treatment of every known site after systemic control and ablation of a resistant site during otherwise effective...
-
Thoracic E22: Metastatic Non-Small-Cell Lung Cancer and Radiation Therapy–Systemic Therapy Integration
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 22 focuses on integrating radiation and systemic therapy in metastatic non-small cell lung cancer without allowing two independent treatment calendars to collide. The durable skill is not memorizing one universal drug-hold...
-
Thoracic E21: Stage III Non-Small Cell Lung Cancer and Small Cell Lung Cancer Mock Oral
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 21 is a three-block mock oral covering fit unresectable stage III non-small cell lung cancer, frail unresectable stage III disease, and small cell lung cancer. The cases test concurrent versus modified chemoradiation…
more -
Thoracic E20: Extensive-Stage Small Cell Lung Cancer and Thoracic Radiation
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 20 clarifies the selective role of thoracic radiation in extensive-stage small cell lung cancer. We distinguish consolidative treatment after a favorable systemic response from palliative treatment for symptoms or threatened...
-
Thoracic E19: PCI, MRI Surveillance, and Hippocampal Avoidance
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 19 examines the decision between prophylactic cranial irradiation and structured MRI surveillance in small cell lung cancer, including the role of hippocampal avoidance. We place the evidence in its imaging and treatment era...
-
Thoracic E18: Limited-Stage Small Cell Lung Cancer: Timing, Planning, and Consolidation
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 18 follows limited-stage small cell lung cancer from the start of chemotherapy through thoracic radiation planning and post-treatment decisions. We discuss treatment timing, fractionation, target construction, the use of…
more -
Thoracic E17: SCLC Foundations and Curative Treatment
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 17 establishes the foundations of small cell lung cancer care: pathologic confirmation, complete staging, mandatory attention to brain imaging, the rare role of surgery, and entry into curative treatment for limited-stage...
-
Thoracic E16: After Definitive CRT: Consolidation, Toxicity, and Relapse
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 16 begins where definitive chemoradiation ends. We organize post-treatment care around three competing possibilities: eligibility for consolidation therapy, clinically important toxicity, and early relapse or progression.…
more -
Thoracic E15: Stage Three Targeting and Treatment Planning
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 15 is a planning-focused guide to definitive radiation for stage III non-small cell lung cancer. We move from simulation and motion assessment to gross disease, nodal volumes, target margins, technique, image guidance,...
-
Thoracic E14: Definitive Stage Three Management
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 14 builds the definitive treatment framework for unresectable stage III non-small cell lung cancer. We begin by confirming a curable nonsurgical disease state, completing stage-defining workup, and deciding whether the…
more -
Thoracic E13: Localized and Resectable Non-Small Cell Lung Cancer Mock Oral
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 13 is a three-block mock oral in localized and resectable non-small cell lung cancer. The cases move from surgery versus stereotactic radiation for peripheral disease, to central and ultracentral anatomy, and then to...
-
Thoracic E12: PORT: Evidence, Selection, and Planning
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 12 takes a selective, evidence-based approach to postoperative radiation therapy for non-small cell lung cancer. We reconstruct residual disease, margin status, nodal burden and geography, surgical quality, the preoperative...
-
Thoracic E11: Trimodality Therapy and Superior Sulcus Tumors
Welcome back to Rad Onc Smart Review: Thoracic Oncology Edition. Episode 11 examines trimodality therapy through the demanding example of a superior sulcus tumor. Before chemotherapy and radiation begin, the team must define thoracic-inlet invasion, nodal status, the feasibility of a...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
Loading similar podcasts...
Frequently Asked Questions
How many episodes does RadOnc Smart Review have?
RadOnc Smart Review currently has 310 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is RadOnc Smart Review about?
AI Generated Podcast reviewing various topics in Radiation Oncology for Residents on the go.
How often does RadOnc Smart Review release new episodes?
RadOnc Smart Review publishes regularly with 310 episodes available. Check the episode list for the typical release schedule.
Where can I listen to RadOnc Smart Review?
You can listen to RadOnc Smart Review on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts RadOnc Smart Review?
RadOnc Smart Review is created and hosted by Abass Conteh.
URL copied to clipboard!